Mount Desert Island Biological Laboratory is receiving a $392,463 federal grant to support research for treatment of various diseases, including Alzheimer’s and Parkinson’s.
U.S. Sens. Susan Collins and Angus King announced Wednesday that the funding comes from the National Institute of Diabetes and Digestive and Kidney Diseases, an agency of the U.S. Department of Health and Human Services.
The funding will support MDI Biological Laboratory’s ongoing research on mutations in proteins and aid researchers in developing new drugs to treat diseases like Alzheimer’s.
“The researchers at MDI Biological Laboratory are working tirelessly to expand our understanding of diseases and strategies to advance modern medicine,” Collins and King said in a joint statement. “This funding will support the laboratory as it strives to develop medications and treatments for diseases affecting countless Americans and their families every day.”
Read more
Training budding scientists: Federal funding boosts Maine’s science and technology workforce
Experts at MDI Bio Lab conference see future therapeutics in regenerative medicine